Photo: Monstera

What is the new drug for urinary incontinence?

GEMTESA (vibegron) for the Treatment of Overactive Bladder (OAB) GEMTESA® (vibegron) is a new oral medication indicated for the treatment of overactive bladder (OAB) with signs of urge urinary incontinence (UUI), urgency and urinary frequency in adults.

clinicaltrialsarena.com - GEMTESA (vibegron) for the Treatment of Overactive Bladder ...

Does Cialis treat BPH?

Cialis for once daily use is approved to treat ED, the signs and symptoms of BPH, and ED and the signs and symptoms of BPH in men who have both...

Last updated Jul 5, 2019

Why is tomato good for prostate?

Earlier research in the Adventist Health Study and several other projects internationally suggest high lycopene intake is associated with reduced...

Last updated Sep 18, 2022

Promotion

GEMTESA® (vibegron) is a new oral medication indicated for the treatment of overactive bladder (OAB) with signs of urge urinary incontinence (UUI), urgency and urinary frequency in adults. Developed by Urovant Sciences, a subsidiary of Sumitovant Biopharma, GEMTESA is available as an oral once-daily, oval, light green, film-coated tablets in 75mg strength.

GEMTESA approvals

The FDA approved GEMTESA for the treatment of adults with overactive bladder (OAB) in December 2020. GEMTESA will be launched in the US late in the first quarter of 2021.

Overactive bladder (OAB) causes and symptoms

Overactive bladder (OAB) is a clinical condition that happens when the muscles of the bladder contract involuntarily. When the bladder muscle contracts too frequently or at the wrong time, the person might have signs of an OAB. The condition is marked by a sudden need to urinate that is difficult to manage with or without accidental urinary discharge and typically with elevated urinary frequency. Unintentional urinary leakage due to urgency is referred to as UUI. Excessive urination (usually eight or more times in 24 hours) and nocturnal symptoms are some of the other symptoms of OAB. More than 30 million people in the US suffer from troubling symptoms of OAB, which can significantly hamper the day-to-day activities of the patients.

Vibegron’s mechanism of action

Vibegron is a small molecule, selective human beta-3 adrenergic agonist that binds to and activates the beta-3 adrenergic receptor on the bladder. Activation of the beta-3 adrenergic receptor increases the capacity of the bladder by calming the detrusor smooth muscle during the bladder filling.

The drug’s safety and efficacy in children remain unestablished.

Clinical trials on GEMTESA

FDA approval of GEMTESA was based on a 12-week, double-blind, randomised, placebo-controlled, and active-controlled clinical trial named EMPOWUR. A total of 1,515 OAB patients were randomised in 5:5:4 ratio to receive either GEMTESA 75mg (n=545), placebo (n=540) or active control (tolterodine; n=430) orally once daily for 12 weeks. “The FDA approved GEMTESA for the treatment of adults with overactive bladder (OAB) in December 2020.” The patients with signs of OAB for at least three months with an average of eight or more micturitions a day and at least one UUI a day, or an average of eight or more micturitions a day and at least three urgency episodes a day were eligible to enter the trial. The study population included OAB opioid-naive patients, as well as patients who had undergone previous OAB drug therapy. The co-primary endpoints of the trial were changes in micturition frequency and UUI episodes at week 12. At 12 weeks, micturition reduced by an adjusted mean of 1.8 episodes a day in patients receiving GEMTESA compared to 1.3 episodes a day for placebo and 1.6 episodes a day for tolterodine. In incontinent patients, urge incontinence episodes decreased by an adjusted mean of two episodes a day for GEMTESA versus 1.4 for placebo and 1.8 for tolterodine. GEMTESA was also substantially superior to placebo for secondary endpoints including the number of urgency episodes, volume per urination, and proportion of incontinent patients with a 75% or higher reduction in the urge incontinence episode. The most common adverse reactions of GEMTESA in patients during the trial were diarrhoea, nausea, headache, upper respiratory tract infection and nasopharyngitis.

How much zinc should I take daily for BPH?

Make sure that you're getting the recommended daily allowance — 15 milligrams per day — of zinc through foods such as pumpkin seeds (in the shell),...

Last updated Jun 12, 2019

What triggers lymphoma?

In most cases, there is no known cause for lymphoma. However, for a few types of lymphoma, scientists have identified a cause: Most cases of...

Last updated Jul 19, 2021

Promotion

Should I see a gynecologist for pelvic pain?

Sudden and severe pelvic pain could be a medical emergency. Seek prompt medical attention. Be sure to get pelvic pain checked by your doctor if it's new, it disrupts your daily life, or it gets worse over time.

mayoclinic.org - Pelvic pain When to see a doctor - Mayo Clinic

Pelvic pain is pain in the lowest part of your abdomen and pelvis. Pelvic pain might refer to symptoms arising from the reproductive, urinary or digestive systems, or from muscles and ligaments in the pelvis. Depending on its source, pelvic pain can be dull or sharp; it might be constant or off and on (intermittent); and it might be mild, moderate or severe. Pelvic pain can spread to your lower back, buttocks or thighs. You might notice pelvic pain only at certain times, such as when you use the bathroom or have sex. Pelvic pain can occur suddenly, sharply and briefly (acute) or over the long term (chronic). Chronic pelvic pain refers to any constant or intermittent pelvic pain that has been present for six months or more. Several types of diseases and conditions can cause pelvic pain. Chronic pelvic pain can result from more than one condition. Pelvic pain can arise from your digestive, reproductive or urinary system. Recently, doctors have recognized that some pelvic pain, particularly chronic pelvic pain, can also arise from muscles and connective tissue (ligaments) in the structures of the pelvic floor. Pelvic pain might also be caused by irritation of nerves in the pelvis. Sudden and severe pelvic pain could be a medical emergency. Seek prompt medical attention. Be sure to get pelvic pain checked by your doctor if it's new, it disrupts your daily life, or it gets worse over time.

Will urinary retention go away itself?

Urinary incontinence almost never goes away on its own. But there are steps you can take to help relieve your symptoms. "Alleviating urinary...

Last updated Mar 9, 2022

What vitamins help fatigue?

The 5 Best Vitamins for Energy & Tiredness 1) Vitamin B1 (Thiamin) 2) Vitamin B2 (Riboflavin) 3) Vitamin B3 (Niacin)

Last updated Jul 5, 2021

Promotion

Why does zinc make you come more?

In fact, it is the most crucial mineral that your body needs to produce more semen and testosterone. Testosterone is the hormone that is...

Last updated Oct 19, 2018

Promotion

What is the earliest symptom of prostate cancer?

Early prostate cancer symptoms Burning or pain during urination. Difficulty urinating, or trouble starting and stopping while urinating. More...

Last updated Apr 5, 2021